The research indicates that macrophages previously described as "pro-fibrotic" are insufficient to cause fibrosis on their ...

“This preclinical proof of concept underscores our engineered macrophages’ ability to home in on fibrotic tissues, deliver therapeutic agents, and notably reduce liver fibrosis,” stated ...